- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03015545
The Effects of WBV on Muscle Stiffness and Reflex Activity in Stroke.
The Effects of Whole Body Vibration (WBV) on Muscle Stiffness and Reflex Activity in People After Stroke.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Spastic hypertonia is common after stroke. Whole-body vibration (WBV) is known to have modulatory effects of muscle reflex activity and blood flow in other populations and thus have potential applications in management of spastic hypertonia post-stroke. However, the potential effects of WBV on leg muscle stiffness in stroke rehabilitation remains unknown. Scientific evidence is warranted to fill the knowledge gap.
Purpose This study aims to investigate the acute effect of WBV on leg muscle H-reflex, stiffness and blood perfusion in people with chronic stroke.
Methods Individuals with chronic stroke will be recruited from community self-help groups and existing patient database. Relevant information (e.g. demographic information, medical history) will be obtained from medical records and subject interviews. Each subject will have to fulfill the following inclusion criteria: (1) diagnosis of chronic stroke, (2) community-dwelling, (3) able to follow simple verbal instructions. Exclusion criteria are: (1) other diagnoses of neurological conditions, (2) significant musculoskeletal conditions (e.g. amputations), (3) metal implants in the lower extremity or spine, (4) recent fracture in the lower extremity, (5) diagnosis of osteoporosis, (6) vestibular disorders, (7) peripheral vascular disease, and (11) other serious illnesses or contraindications to exercise.
This is a single-blinded randomized within-patient cross-over study. Each participant was evaluated for the soleus H-reflex, stiffness and blood perfusion of the medial gastrocnemius (MG) using ultrasound on both sides before and after either a 5-minute WBV intervention (30 Hertz, 1.5mm, knee flexed 60 degrees) or a no-WBV condition (5 minutes). The measurements were performed at baseline and every 1-min post-intervention up to 5 minutes. The outcomes generated included the soleus H/M ratio, shear modulus and vascular index (VI) of the MG muscle.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Kowloon
-
Hung Hom, Kowloon, Hong Kong
- The Hong Kong Polytechnic University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult with a diagnosis of a hemispheric stroke >6 months,
- Medically stable,
- Able to stand independently for at least 1 minute and
- Mas score >1 measured at the ankle plantar flexors.
Exclusion Criteria:
- Brainstem or cerebellar stroke,
- Other neurological condition,
- Serious musculoskeletal or cardiovascular disease,
- Severe contracture of the ankle that the cannot be put in the neutral position.
- Metal implants or recent fractures in the lower extremities or spine,
- Fresh skin wound in lower extremities, especially popliteal fossa
- Other severe illnesses or contraindication for exercise.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Control
This group will stand with knee flexion 60 degrees on the same vibration platform for 60 seconds for 5 times with 60-seconds rest interval, but no vibration will be given.
|
standing on the vibration platform, with no vibration signals delivered.
standing on the vibration platform, with no vibration signals delivered.
|
|
ACTIVE_COMPARATOR: High intensity whole body vibration
This group will stand with knee flexion 60 degrees on the same vibration platform for 60 seconds for 5 times with 60-seconds rest interval.
The whole body vibration platform will be set with frequency at 30Hz and amplitude at 1.5mm.
|
standing on the vibration platform, with WBV at 30Hz, 1.5mm.
standing on the vibration platform, with WBV at 30Hz, 1.5mm.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
H-reflex of paretic soleus muscle
Time Frame: Immediately before the intervention
|
To measure the efficacy of synaptic transmission
|
Immediately before the intervention
|
|
H-reflex of paretic soleus muscle
Time Frame: 1st minute after the intervention
|
To measure the efficacy of synaptic transmission
|
1st minute after the intervention
|
|
H-reflex of paretic soleus muscle
Time Frame: 2nd minute after the intervention
|
To measure the efficacy of synaptic transmission
|
2nd minute after the intervention
|
|
H-reflex of paretic soleus muscle
Time Frame: 3rd minute after the intervention
|
To measure the efficacy of synaptic transmission
|
3rd minute after the intervention
|
|
H-reflex of paretic soleus muscle
Time Frame: 4th minute after the intervention
|
To measure the efficacy of synaptic transmission
|
4th minute after the intervention
|
|
H-reflex of paretic soleus muscle
Time Frame: 5th minute after the intervention
|
To measure the efficacy of synaptic transmission
|
5th minute after the intervention
|
|
Muscle stiffness of paretic medial gastrocnemius
Time Frame: Immediately before the intervention
|
Measured by Supersonic elastography with ankle in neutral position
|
Immediately before the intervention
|
|
Muscle stiffness of paretic medial gastrocnemius
Time Frame: 1st minute after the intervention
|
Measured by Supersonic elastography with ankle in neutral position
|
1st minute after the intervention
|
|
Muscle stiffness of paretic medial gastrocnemius
Time Frame: 2nd minute after the intervention
|
Measured by Supersonic elastography with ankle in neutral position
|
2nd minute after the intervention
|
|
Muscle stiffness of paretic medial gastrocnemius
Time Frame: 3rd minute after the intervention
|
Measured by Supersonic elastography with ankle in neutral position
|
3rd minute after the intervention
|
|
Muscle stiffness of paretic medial gastrocnemius
Time Frame: 4th minute after the intervention
|
Measured by Supersonic elastography with ankle in neutral position
|
4th minute after the intervention
|
|
Muscle stiffness of paretic medial gastrocnemius
Time Frame: 5th minute after the intervention
|
Measured by Supersonic elastography with ankle in neutral position
|
5th minute after the intervention
|
|
H-reflex of non-paretic soleus muscle
Time Frame: Immediately before the intervention
|
To measure the efficacy of synaptic transmission
|
Immediately before the intervention
|
|
H-reflex of non-paretic soleus muscle
Time Frame: 1st minute after the intervention
|
To measure the efficacy of synaptic transmission
|
1st minute after the intervention
|
|
H-reflex of non-paretic soleus muscle
Time Frame: 2nd minute after the intervention
|
To measure the efficacy of synaptic transmission
|
2nd minute after the intervention
|
|
H-reflex of non-paretic soleus muscle
Time Frame: 3rd minute after the intervention
|
To measure the efficacy of synaptic transmission
|
3rd minute after the intervention
|
|
H-reflex of non-paretic soleus muscle
Time Frame: 4th minute after the intervention
|
To measure the efficacy of synaptic transmission
|
4th minute after the intervention
|
|
H-reflex of non-paretic soleus muscle
Time Frame: 5th minute after the intervention
|
To measure the efficacy of synaptic transmission
|
5th minute after the intervention
|
|
Muscle stiffness of non-paretic medial gastrocnemius
Time Frame: Immediately before the intervention
|
Measured by Supersonic elastography with ankle in neutral position
|
Immediately before the intervention
|
|
Muscle stiffness of non-paretic medial gastrocnemius
Time Frame: 1st minute after the intervention
|
Measured by Supersonic elastography with ankle in neutral position
|
1st minute after the intervention
|
|
Muscle stiffness of non-paretic medial gastrocnemius
Time Frame: 2nd minute after the intervention
|
Measured by Supersonic elastography with ankle in neutral position
|
2nd minute after the intervention
|
|
Muscle stiffness of non-paretic medial gastrocnemius
Time Frame: 3th minute after the intervention
|
Measured by Supersonic elastography with ankle in neutral position
|
3th minute after the intervention
|
|
Muscle stiffness of non-paretic medial gastrocnemius
Time Frame: 4th minute after the intervention
|
Measured by Supersonic elastography with ankle in neutral position
|
4th minute after the intervention
|
|
Muscle stiffness of non-paretic medial gastrocnemius
Time Frame: 5th minute after the intervention
|
Measured by Supersonic elastography with ankle in neutral position
|
5th minute after the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intramuscular blood perfusion of paretic medial gastrocnemius muscle
Time Frame: Immediately before the intervention
|
Measured by power Doppler ultrasound
|
Immediately before the intervention
|
|
Intramuscular blood perfusion of paretic medial gastrocnemius muscle
Time Frame: 1 minute after the intervention
|
Measured by power Doppler ultrasound
|
1 minute after the intervention
|
|
Intramuscular blood perfusion of paretic medial gastrocnemius muscle
Time Frame: 2nd minute after the intervention
|
Measured by power Doppler ultrasound
|
2nd minute after the intervention
|
|
Intramuscular blood perfusion of paretic medial gastrocnemius muscle
Time Frame: 3rd minute after the intervention
|
Measured by power Doppler ultrasound
|
3rd minute after the intervention
|
|
Intramuscular blood perfusion of paretic medial gastrocnemius muscle
Time Frame: 4th minute after the intervention
|
Measured by power Doppler ultrasound
|
4th minute after the intervention
|
|
Intramuscular blood perfusion of paretic medial gastrocnemius muscle
Time Frame: 5th minute after the intervention
|
Measured by power Doppler ultrasound
|
5th minute after the intervention
|
|
Intramuscular blood perfusion of non-paretic medial gastrocnemius muscle
Time Frame: Immediately before the intervention
|
Measured by power Doppler ultrasound
|
Immediately before the intervention
|
|
Intramuscular blood perfusion of non-paretic medial gastrocnemius muscle
Time Frame: 1th minute after the intervention
|
Measured by power Doppler ultrasound
|
1th minute after the intervention
|
|
Intramuscular blood perfusion of non-paretic medial gastrocnemius muscle
Time Frame: 2nd minute after the intervention
|
Measured by power Doppler ultrasound
|
2nd minute after the intervention
|
|
Intramuscular blood perfusion of non-paretic medial gastrocnemius muscle
Time Frame: 3rd minute after the intervention
|
Measured by power Doppler ultrasound
|
3rd minute after the intervention
|
|
MoviIntramuscular blood perfusion of non-paretic medial gastrocnemius muscle
Time Frame: 4th minute after the intervention
|
Measured by power Doppler ultrasound
|
4th minute after the intervention
|
|
Intramuscular blood perfusion of non-paretic medial gastrocnemius muscle
Time Frame: 5th minute after the intervention
|
Measured by power Doppler ultrasound
|
5th minute after the intervention
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fugl-Meyer Assessment of Motor Recovery after Stroke--lower extremities
Time Frame: Immediately before the intervention
|
Evaluates and measures motor recovery in post-stroke hemiplegic patients
|
Immediately before the intervention
|
|
Brief Balance Evaluation Systems Test
Time Frame: Immediately before the intervention
|
Immediately before the intervention
|
Collaborators and Investigators
Investigators
- Study Chair: Hector WH Tsang, PhD, Department of Rehabilitation Sciences, The Hong Kong Polytechnic University
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HSEARS20161117007
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on paretic leg-control
-
McMaster UniversityCompleted
-
McMaster UniversityNatural Science and Engineering Research Council of Canada (NSERC)CompletedMuscle Protein Synthesis | Menstrual Cycle | Resistance Exercise | OCPCanada
-
Cleveland State UniversityCompleted
-
Samsung Medical CenterCompletedInfants or Children Undergoing Open Heart SurgeryKorea, Republic of
-
Universidad Miguel Hernandez de ElcheNot yet recruitingHealthy Adult Volunteer | Exercise Induced HypoalgesiaSpain
-
Indiana UniversityNational Institute on Aging (NIA); Purdue UniversityRecruiting
-
Universidade Federal de PernambucoCompleted
-
Investigación en Hemofilia y FisioterapiaCompleted
-
Milton S. Hershey Medical CenterCompleted
-
University Hospital, ToulouseUniversity Hospital, Bordeaux; University Hospital, LimogesCompleted